From €3185EUR$3,500USD£2,731GBP
- Report
- December 2024
- 80 Pages
India
From €3185EUR$3,500USD£2,731GBP
- Report
- March 2025
- 85 Pages
Saudi Arabia
From €3185EUR$3,500USD£2,731GBP
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2024
- 164 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 105 Pages
Europe
From €4323EUR$4,750USD£3,706GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- February 2023
- 240 Pages
Global
From €3249EUR$3,570USD£2,785GBP
Pharmaceutical Services Outsourcing (PSO) is a rapidly growing market within the pharmaceutical manufacturing industry. It involves the transfer of certain activities, such as drug development, clinical trials, and manufacturing, from pharmaceutical companies to third-party service providers. This allows pharmaceutical companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. PSO also helps pharmaceutical companies reduce costs, increase efficiency, and improve quality.
The PSO market is segmented into drug development, clinical trials, and manufacturing services. Drug development services include pre-clinical and clinical research, regulatory affairs, and drug safety. Clinical trials services include clinical trial management, data management, and biostatistics. Manufacturing services include active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging and labeling.
Notable companies in the PSO market include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more